Full Breakdown
Trump Administration Blocks Federal Funding for Gender-Affirming Care of Transgender Youth
8/12/2026, 4:17:36 AM
The Rule and Its Immediate Impact
The Centers for Medicare & Medicaid Services (CMS) issued a final rule that bars Medicaid from paying for “sex-rejecting procedures” for individuals under 18 and prohibits Children’s Health Insurance Program (CHIP) plans from covering the same procedures for people under 19. The rule eliminates federal reimbursement for puberty blockers, hormone therapy and gender-affirming surgeries for minors, while preserving coverage for mental-health services. Beneficiaries already receiving cross-sex hormone therapy may continue to use Medicaid or CHIP for up to six months after the rule’s effective date, scheduled for October 12, 2026. State Medicaid programs can still fund such care with their own dollars.
Background & Context
The policy follows actions taken since President Donald Trump returned to office, including an executive order rescinding federal recognition of gender-affirming care and earlier proposals that would have restricted hospitals from providing the care under Medicare and Medicaid. A prior “conditions of participation” proposal was withdrawn in favor of the current rule, which focuses on federal funding rather than hospital participation.
Data & Statistics
- More than 35,000 public comments were submitted, the majority opposing the change.
- 27 states have enacted bans on gender-affirming care for minors; roughly half of transgender youth aged 13-17 live in such states.
- In 2023, Medicaid spent about $31 million on gender-dysphoria treatment, with $28 million for hormone therapy or puberty blockers and $2.3 million for surgical services.
- Less than 1 % of minors received gender-affirming surgery, according to a 2024 study.
- The administration projects a reduction of $235 million in Medicaid and CHIP spending over the next decade.
Official Statements & Responses
Health and Human Services Secretary Robert F. announced the change on social media, asserting that the policy would prevent “innocent children” from undergoing “barbaric surgeries and practices.” The rule explicitly allows continued federal coverage for mental-health services for transgender youth.
Verbatim Quotes
- “We are not going to pay for our innocent children to undergo these barbaric surgeries and practices, which result in unthinkable and irreversible harm to their young bodies,” — Mr. Trump
- “Personal medical decisions should be made by individual patients, their doctors, and their families – not by a one-size-fits-all mandate from the federal government,” — Rodrigo Heng-Lehtinen, The Trevor Project
- “The entire purpose of Medicaid is that Medicaid is health insurance for low-income people. CHIP is health insurance for children from low-income families,” — Adrian Shanker
Conflicting Reports & Gaps
Sources differ on the exact effective date: some report October 12, 2026, while others cite a later date. Coverage details also vary; some outlets note that hormone therapy will be phased out with a six-month transition period, whereas others state that puberty blockers cease immediately. The precise amount of current federal spending on gender-affirming care remains unclear, with CMS declining to comment.
What’s Next
The rule will become operative in October 2026, after which states must decide whether to allocate their own funds for gender-affirming treatments. Legal challenges are expected, and advocacy groups have signaled intent to pursue litigation. The policy’s impact on low-income families will likely be monitored in upcoming health-policy analyses.
